GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives $92.50 Consensus Target Price from Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned a consensus rating of “Hold” from the fourteen research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $92.50.

Several equities research analysts have commented on GEHC shares. The Goldman Sachs Group restated a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Jefferies Financial Group increased their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Piper Sandler raised their price target on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, January 30th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their price target for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Finally, Barclays increased their price objective on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Allianz SE raised its holdings in shares of GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares during the period. E Fund Management Hong Kong Co. Ltd. grew its position in GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after acquiring an additional 196 shares in the last quarter. Godsey & Gibb Inc. purchased a new stake in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Laurel Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth $26,000. Finally, Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $27,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $79.20 on Friday. GE HealthCare Technologies has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The firm has a 50 day moving average price of $82.62 and a 200 day moving average price of $77.59. The company has a market cap of $36.10 billion, a price-to-earnings ratio of 17.37, a PEG ratio of 1.75 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter last year, the firm posted $1.45 earnings per share. GE HealthCare Technologies’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts predict that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.